Cadalimab 40mg/0.8ml Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Adalimumab (40mg/0.8ml)
Overview Cadalimab 40mg/0.8ml Injection
Cadalimab injection (40mg/0.8ml) treats diverse inflammatory conditions including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. It alleviates inflammation, pain, and associated redness, enhancing mobility. Administration is strictly by a healthcare provider; self-injection is prohibited. Consistent daily dosing maximizes efficacy; complete the prescribed course, even with symptom improvement. Common side effects may include headache, sinusitis, skin rash, upper respiratory infections, and injection site reactions (pain, redness, swelling). Persistent or worsening side effects warrant medical attention; management strategies may be available. Prior to treatment, disclose any cardiac, renal, or hepatic issues, and list all current medications. Pregnant or breastfeeding individuals should consult their physician before using Cadalimab.
Uses of Cadalimab 40mg/0.8ml Injection
Spondyloarthropathy|Inflammatory joint disease|Psoriatic disease|Ulcerative bowel disease|Inflammatory bowel disease
Major Benefits of Cadalimab 40mg/0.8ml Injection:
The medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Cadalimab 40mg/0.8ml Injection:
- Headache
- Sinus inflammation
- Rash
- Upper respiratory tract infection
- Injection site reaction
How to use Cadalimab 40mg/0.8ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cadalimab 40mg/0.8ml Injection works:
Cadalimab's 40mg/0.8ml injection neutralizes inflammatory mediators, thereby alleviating swelling and redness characteristic of specific arthritic conditions.
SAFETY ADVICE
AlcoholSAFE
Cadalimab 40mg/0.8ml Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Cadalimab 40mg/0.8ml Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Cadalimab 40mg/0.8ml Injection safely. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Administration of Cadalimab 40mg/0.8ml Injection may induce adverse reactions impacting driving capabilities. These reactions can include dizziness and visual impairment, potentially compromising safe driving.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cadalimab 40mg/0.8ml Injection to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Data regarding Cadalimab 40mg/0.8ml Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Cadalimab 40mg/0.8ml Injection :
Should you forget a dose of the 40mg/0.8ml Cadalimab injection, seek medical advice.
Facts to Know About Cadalimab 40mg/0.8ml Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs) |
3,018 People bought this recently